Carisoprodol
Product Images NDC 29033-214

3 FDA label images from Nostrum Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 29033-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nostrum Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carisoprodol Chemical Structure (Carisoprodol Figure 1)

Carisoprodol Chemical Structure (Carisoprodol Figure 1)
Chemical structure diagram of Carisoprodol showing its molecular arrangement including amide, ester, and branched alkyl groups.*
FDA Label Image

Package Label (Principal Display Panel – 30-count Bottle, 250 mg Tablets)

Package Label (Principal Display Panel – 30-count Bottle, 250 mg Tablets)
Carisoprodol Tablets, USP 250 mg label from Nostrum Laboratories, Inc. The label states each tablet contains 250 mg of Carisoprodol. It includes storage instructions for 20° to 25° C and mentions dispensing in a tight container. The package contains 100 tablets and has a barcode and NDC 29033-207-01.*
FDA Label Image

Package Label (Principal Display Panel – 100-count Carton, 250 mg Tablets)

Package Label (Principal Display Panel – 100-count Carton, 250 mg Tablets)
Label for Carisoprodol tablets, USP 350 mg, manufactured by Nostrum Laboratories, Inc. The label states each tablet contains 350 mg of Carisoprodol and includes instructions for usual dosage to see enclosed prescribing information. Storage instructions specify 20° to 25°C (68° to 77°F) and dispensing in a tight container. The package contains 100 tablets and displays an NDC code and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.